Stockscreener 앱 받기
0.00
100.00%
-15.20
시장 영업 전:
15.20
15.20
+
Euda Health Holdings Limited 주식(EUDA)의 최신 뉴스
EUDAW Drops 10% as Thin Trading Continues at $0.02 Support LevelSocial Sentiment - newsline.com
EUDAW Slides 5% to $0.02: Penny-Stock Warrant Tests Critical FloorStandard Deviation - newsline.com
EUDA Health (NASDAQ: EUDA) suspends ATM offering, files termination notice - Stock Titan
EUDA Health Halts and Moves to Terminate $10 Million ATM Equity Program - TipRanks
[6-K] EUDA Health Holdings Ltd Current Report (Foreign Issuer) - Stock Titan
Tan Meng Dong holds 15.3% of EUDA (NASDAQ: EUDA) in amended Schedule 13G - Stock Titan
Zhang Xin reports 295,000 shares in EUDA (EUDA) — 9.85% stake - Stock Titan
EUDA Health regains Nasdaq compliance after meeting minimum market value standards - MSN
EUDA Health Restores Nasdaq Compliance After Market Value Shortfall - The Globe and Mail
EUDA Health expands product line with new stem cell mask - Investing.com UK
EUDA Health (NASDAQ: EUDA) debuts Regenixé stem cell secretome mask - Stock Titan
EUDA Health (NASDAQ: EUDA) regains Nasdaq MVLS listing compliance - Stock Titan
EUDA Health regains Nasdaq listing compliance By Investing.com - Investing.com Australia
EUDA Health expands product line with new stem cell mask By Investing.com - Investing.com South Africa
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask - The Manila Times
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency - The Manila Times
EUDA Health Holdings Limited Regains Compliance with Nasdaq Listing Requirements - Quiver Quantitative
EUDA Health regains Nasdaq listing compliance - Investing.com
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell ... - Caledonian Record
Stem cell skincare: EUDA targets $8B face mask market with Regenixé - Stock Titan
EUDA Health restores Nasdaq listing compliance after value shortfall - Stock Titan
EUDA Health Holdings (EUDA) Slides 3.78% as Stock Tests Key Support LevelsGrowth ETF - newsline.com
EUDA Health Holdings Warrant (EUDAW) Holds at $0.03 Support After 3.79% DeclineMonthly Profile - newsline.com
EUDA Health Holdings (EUDA) Shows Minimal Movement as Shares Test Support ZoneFibonacci Arc - The Legal Advocate
EUDAEuda Health Holdings Limited Stock Price and Quote - Finviz
EUDA Health Holdings (EUDA) Rallies 3.69% as Buyers Step In Near SupportTriple Bottom - The Legal Advocate
EUDA Health (NASDAQ: EUDA) registers 947,963 shares for resale; MVLS notice - Stock Titan
EUDA Health Warrants (EUDAW) Hold Steady at $0.04 – Flat Session Highlights Lack of CatalystsStock News - The Legal Advocate
EUDAW Price History for Euda Health Holdings Ltd WT Stock - Barchart.com
Euda Health Holdings LimitedWarrant (NQ: EUDAW - FinancialContent
EUDA Stock Price, Quote & Chart | EUDA HEALTH HOLDINGS LTD (NASDAQ:EUDA) - ChartMill
Euda Health Holdings stock (US29821P1030): Trading at 14.40 USD with 4.65% gain - AD HOC NEWS
TradingKey - TradingKey
The fundamentals driving EUDA (EUDA) everyone should understand (+2.38%) 2026-05-08Trend Following Picks - The Legal Advocate
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
EUDAW (EUDA) management lays out core strategic growth priorities for 2024 following its latest quarterly earnings update.Community Watchlist - Newser
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
EUDA Health Showcases Shenzhen Inno’s Government-Backed TCR-T Cell Therapy Program - TipRanks
Going concern warning and heavy financing at EUDA (NASDAQ: EUDA) - Stock Titan
EUDA Health Warned by Nasdaq Over Market Value, Given Until October to Regain Compliance - The Globe and Mail
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development - ChartMill
0.00%
0.71%
자본화:
|
볼륨(24시간):